Smiths Detection has entered into an agreement to
acquire PathSensors, a leading bio-technology solutions and
environmental-testing company based in Baltimore, MD.
The acquisition expands Smiths Detection’s sensing
capabilities across the CBRNE (chemical, biological, radiological,
nuclear and explosive) spectrum.
PathSensors provides high-speed, highly sensitive
pathogen-detection and biothreat solutions and has developed a
robust fieldable method of identifying biological threats in
The company shares a similar customer base to that which
Smiths Detection serves for chemical-threat detection, while also
allowing for expansion into adjacencies such as food and
PathSensors offers multiple assays that are
already available, at an independently verified speed and
sensitivity data, which offer an opportunity to develop their
The transaction will enable Smiths Detection
to accelerate its position in biological-detection capabilities.
“The acquisition of PathSensors will allow us to
broaden our detection capabilities within the biological spectrum,
which is becoming more relevant in the current environment,” said
Roland Carter, President of Smiths Detection. “This is consistent
with our approach to increase our focus on investing selectively
in technology and innovation for the purpose of getting closer to
our customers and expanding into new adjacencies.”
The contract is subject to customary closing
conditions and is expected to conclude within the next four weeks.
Details of the transaction have not been disclosed.